NASDAQ$ACHC

Acadia Healthcare Company Inc. · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Acadia Healthcare's financial results for Q2 2020 were announced, showing a decrease in revenue compared to the same period in 2019, but highlighting the ongoing need for their services.

Acadia Healthcare reported a decrease in revenue for Q2 2020, with $750.3 million compared to $789.4 million in Q2 2019. Net income attributable to Acadia stockholders was $41.1 million, or $0.46 per diluted share, compared to $48.1 million, or $0.55 per diluted share, for the same period in 2019.

  • Revenue for the second quarter of 2020 was $750.3 million, compared to $789.4 million for the second quarter of 2019.
  • Net income attributable to Acadia stockholders for the second quarter of 2020 was $41.1 million, or $0.46 per diluted share.
  • U.S. same facility revenue decreased 3.4%, including a 0.7% decrease in patient days and a 2.7% decrease in revenue per patient day, compared to the second quarter last year.
  • As of June 30, 2020, the Company had $212 million in cash and cash equivalents.

Headline financials

Total Revenue

$750M

Previous: $789M-4.9%
EPS (adj)

$0.54

Previous: $0.61-11.5%
US Same-Facility Rev. Growth

-3.4%

No prior period
US Same-Facility Patient Days Growth

-0.7%

No prior period
US Same-Facility Rev/Day Growth

-2.7%

No prior period
Capital Expenditures

-$132M

Previous: -$139M+5.1%
Free Cash Flow

-$91M

Previous: -$91M-0.0%
Net Income

$41.1M

Previous: $48.1M-14.7%
Operating Income

-$227M

Previous: $159M-242.8%
Gross Profit

$18.1M

Previous: $328M-94.5%
Cash & Equivalents

$212M

Previous: $43.5M+386.8%
Total Assets

$6.83B

Previous: $6.79B+0.6%
Stock-Based Comp

$5.81M

Previous: $4.18M+38.9%

Revenue & EPS history

Acadia Healthcare · Revenue · Quarterly

$750M

Q2 2020-4.9%vs Q2 2019
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Forward guidance

Acadia believes there will continue to be a significant need for their services as the associated challenges brought on by the pandemic continue to affect everyone.

Tailwinds

  • Strong demand for mental health and substance use treatments
  • Ongoing need for services due to the pandemic
  • Investments to serve patients’ needs through bed expansion
  • Extension of market reach
  • Advancement of market leadership as a behavioral healthcare facilities operator

Headwinds

  • Impact of the COVID-19 pandemic
  • Potential difficulties operating business in light of political and economic instability in the U.K.
  • Impact of fluctuations in foreign exchange rates
  • Potential reductions in payments received from government and third-party payors
  • Risk of not generating sufficient cash from operations to service its debt

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+1.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+2.5%

Avg return

30 days after

60%

38 / 63 earnings

Positive

+23.1%

Q3 2020

Best reaction

-26.9%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+0.3%-16.0%
Q4 2025+21.4%+36.5%+33.4%
Q3 2025-5.5%-10.2%-25.2%
Q1 2025+4.2%+1.2%-14.4%
Q4 2024-25.5%-26.3%-25.2%
Q3 2024-17.3%-18.0%-21.3%
Q2 2024+10.0%+5.4%+21.6%
Q1 2024-9.8%-8.3%-6.8%
Q4 2023-2.4%-1.8%-7.3%
Q3 2023-1.7%+1.1%+0.5%
Q2 2023+7.8%+6.5%+2.9%
Q1 2023-1.3%-4.4%-6.0%
Q4 2022-9.6%-7.3%-12.1%
Q3 2022-3.4%-5.5%+7.2%
Q2 2022+3.6%+3.9%+4.8%
Q1 2022+8.0%+5.4%+6.4%
Q4 2021+6.5%+9.3%+15.3%
Q3 2021+10.5%+11.8%+3.0%
Q2 2021+3.1%+1.3%+8.0%
Q1 2021-1.1%+1.1%+4.4%
Q4 2020+1.5%+2.5%+6.0%
Q3 2020+23.1%+28.7%+49.1%
Q2 2020+2.3%+2.7%-0.1%
Q1 2020+16.7%+18.2%+26.7%
Q4 2019-5.9%+6.0%+100.5%
Q3 2019-3.5%-2.0%+2.5%
Q2 2019-3.3%-12.0%-19.6%
Q1 2019+0.0%+3.2%+1.4%
Q4 2018+15.9%+11.7%+11.7%
Q3 2018-12.8%-5.0%-26.0%
Q2 2018-10.6%-7.4%-8.0%
Q1 2018+9.0%+11.7%+13.0%
Q4 2017+8.5%+6.8%+8.4%
Q3 2017-26.9%-25.6%-30.7%
Q2 2017+7.6%+5.7%-7.5%
Q1 2017-3.1%+0.0%-2.4%
Q4 2016+5.4%+4.9%-1.7%
Q3 2016+3.1%+3.8%+5.9%
Q2 2016-1.3%-0.8%-4.8%
Q1 2016-0.8%
Q4 2015+5.7%
Q3 2015+9.4%
Q2 2015+3.4%
Q1 2015-2.9%
Q4 2014-0.4%
Q3 2014+11.2%
Q2 2014-2.1%
Q1 2014+0.4%
Q4 2013-2.8%
Q3 2013+9.0%
Q2 2013+8.2%
Q1 2013+2.9%
Q4 2009+2.3%
Q4 2012+0.1%
Q3 2012+2.3%
Q2 2012+7.5%
Q2 2011+4.4%
Q1 2012+6.5%
Q1 2011-1.0%
Q4 2011+3.3%
Q4 2010+0.1%
Q3 2011+0.1%
Q3 2010+0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro